Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Resectable”

177 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 177 results

Early research (Phase 1)UnknownNCT03703063
What this trial is testing

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Benaroya Research Institute 30
Not applicableStudy completedNCT02218801
What this trial is testing

A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program

Who this might be right for
Liver MetastasisColorectal Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 219
Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9
Not applicableUnknownNCT03443921
What this trial is testing

Divestment for Artery-involved Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic CancerNeoadjuvant Therapy+1 more
The First Affiliated Hospital with Nanjing Medical University 122
Not applicableUnknownNCT02781012
What this trial is testing

Project Survival-Prospective Biomarker Discovery

Who this might be right for
Pancreatic NeoplasmsPancreatic CancerPancreatitis+2 more
Pancreatic Cancer Research Team 436
Early research (Phase 1)Not Yet RecruitingNCT07488884
What this trial is testing

Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectablePancreatic Cancer
ImmunityBio, Inc. 30
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Testing effectiveness (Phase 2)Looking for participantsNCT06538857
What this trial is testing

CEB-01 in Locally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
CEBIOTEX 39
Early research (Phase 1)Study completedNCT02308722
What this trial is testing

SBRT Pre-operatively for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Oxford 12
Testing effectiveness (Phase 2)Looking for participantsNCT06387810
What this trial is testing

Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Cancer
Peking Union Medical College Hospital 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT02446093
What this trial is testing

Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Borderline Resectable Pancreatic Adenocarcinoma
Candel Therapeutics, Inc. 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07415525
What this trial is testing

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic Adenocarcinoma
Zhejiang University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05825066
What this trial is testing

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma
Wake Forest University Health Sciences 64
Testing effectiveness (Phase 2)Study completedNCT03496662
What this trial is testing

BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine 40
Testing effectiveness (Phase 2)Ended earlyNCT04176952
What this trial is testing

PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 31
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT04247165
What this trial is testing

Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.

Who this might be right for
Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
Herlev Hospital 55
Testing effectiveness (Phase 2)Study completedNCT01661088
What this trial is testing

Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients

Who this might be right for
Pancreatic Cancer
University of Michigan Rogel Cancer Center 25
Not applicableWithdrawnNCT05379907
What this trial is testing

Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Inova Health Care Services
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Load More Results